Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong · Delayed Price · Currency is HKD 2.200
-0.070 (-3.08%)
Aug 27, 2026, 4:08 PM HKT
HKG:2185 Market Cap
HKG:2185 has a market cap or net worth of 552.56 million as of August 27, 2026. Its market cap has decreased by -72.91% in one year.
Market Cap
552.56M
Enterprise Value
495.25M
Revenue
44.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.20
ChartMarket Cap Chart
Since December 23, 2021, HKG:2185's market cap has decreased from 4.90B to 552.56M, a decrease of -88.73%. That is a compound annual growth rate of -37.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 552.56M | -60.79% |
| Dec 31, 2025 | 1.41B | 253.05% |
| Dec 31, 2024 | 399.20M | -52.05% |
| Dec 29, 2023 | 832.49M | -41.56% |
| Dec 30, 2022 | 1.42B | -78.41% |
| Dec 31, 2021 | 6.60B | 34.58% |
| Dec 23, 2021 | 4.90B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunho Biologics | 970.43M |
| JW (Cayman) Therapeutics Co. | 872.67M |
| Kintor Pharmaceutical | 834.54M |
| 3D Medicines | 750.06M |
| Brii Biosciences | 743.46M |
| Cutia Therapeutics | 726.74M |
| Wuhan YZY Biopharma | 639.70M |
| B&K Corporation | 619.47M |